Abstract. Recent studies show that the serologically defined HLA-A2 molecule can be subdivided according to functional and biochemical characteristics. By the use of various HLA-A2-specific cytotoxic T lymphocytes (CTLs) and isoelectric focusing, the serologically homogeneous HLA-A2 molecule can be divided into four subtypes. The polymorphism of the serologically defined HLA-A2 molecule has also been demonstrated by the use of HLA-A2-restricted CTLs.
Introduction
The genetic fine structure of the HLA specificities can now be studied by the use of a variety of biochemical and immunobiological techniques. One of these techniques, namely, the use of cytotoxic T lymphocytes (CTLs), has been shown to be particularly effective for that purpose. The results of numerous studies indicate that serologically defined HLA-molecules can be subdivided by cellular reagents (Goulmy et al. 1976 , 1982a , Bradley et al. 1978 , Biddison et al. 1980 , Kato et al. 1982 , Horai et al. 1982 , Spits et al. 1982 , Pfeffer and Thorsby 1982 , van der Poel et al. 1983a , Gaston et al. 1983 .
Determination of polymorphism within the serologically defined HLA-A2 molecule has been demonstrated by the use of HLA-A2-restricted CTLs, namely, HLA-restricted influenza virus immune T cells (Biddison et al. 1980) , Epstein-Barr virus-specific CTLs (Gaston et al. 1983) , HLA-restricted H-Y-specific cytotoxic T cells (Goulmy et al. 1982a, Pfeffer and Thorsby 1982) , and by the use of HLA-A2-specific alloimmune CTLs (Horai et al. 1982 , van der Poel et al. 1983a .
Comprehensive analyses of the heterogeneity of HLA-A2 molecules using HLArestricted virus-specific CTLs as well as alloimmune CTLs revealed more variability of recognition sites than anticipated , van der Poel et al. 1983a . In a combined biochemical and immune CTL analysis reported earlier (van der Poel et al. 1983b), we described four distinct HLA-A2 subtypes, of which the major HLA-A2 subtype (i. e., HLA-A2.1) includes 89% of the serologically defined HLA-A2 antigen (Horai et al. 1982 , van der Poel et al. 1983a .
Human CTL l;esponses to the male-specific H-Y antigen (Goulmy et al. 1977 , 1979 , Singal et al. 1981 , Pfeffer and Thorsby 1982 and to minor transplantation antigens (Goulmy et al. 1982b , Elkins et al. 1982 , Tekolfand Shaw 1983 have shown to be restricted by self HLA-A and -B molecules. The HLA-restricted anti-H-Y and antiminor H antigen (designated HA) CTLs, available in our laboratory, recognize the HLA-A2.1 major subtype defined by HLA-A2-specific alloimmune CTLs. Thus, HLA-A2-restricted anti-H-Y CTLs failed to recognize lymphocytes of the male HLA-A2 variant "M7" (Goulmy et al. 1982a) , originally detected as an HLA-A2 variant by HLA-A2-specific influenza virus immune T cells (Biddison et al. 1980) . The aim of this study was to investigate the relationship between the recognition patterns of our two types of CTLs (i. e., HLA-A2-restricted anti-H-Y and antiminor HA) at the level of the restricting HLA-A2 molecule. To that end, we analyzed the reaction patterns and discriminatory capacity of the anti-H-Y and antiminor HA CTLs on a series of HLA-A2 variants belonging to four distinct HLA-A2 subtypes. We report here that HLA-A2-restricted anti-H-Y and HLA-A2-restricted antiminor "HA" CTLs, in all except one case studied so far, failed to recognize HLA-A2 subtypes as defined by alloimmune CTLs. These results lead us to the conclusion that in most but not all cases HLA-restricted antiminor H CTLs and alloimmune HLA-A2 major subtype CTLs both make use of the same epitope(s) on class I molecules for cellular recognition. We will discuss the possibility that MHCrestricted CTLs directed to two different minor transplantation antigens may use different epitopes for recognition.
Materials and Methods
AUoimmune HLA-A2-specific CTLs. Four cytotoxic reagents were generated against the HLA-A2 antigen using finrelated individuals which shared all but the sensitizing HLA-A2 antigen (van der Poel et al. 1983 a) . Eleven percent of the HLA-A2-seropositive lymphocytes used as target cells were identified as HLA-A2 variants. The HLA-A2 serologically defined specificity could be divided into four subtypes based on the reactivity patterns in cell-mediated lympholysis (CML) using (a) alloimmune major subtype HLA-A2-specific CTLs and alloimmune minor subtype HLA-A2-specific CTLs, (b) cold target competition experiments, and (c) biochemical analyses (van der Poel et al. 1983a, b) . We refer to them as HLA-A2.1 (major subtype, 89% of the serologically defined HLA-A2 specificity), HLA A2.2 (minor subtype), HLA-A2.3 (minor subtype), and HLA-A2.4 type (minor subtype). Lymphocytes were obtained from 15 individuals who carried the subtypes A2.2, A2.3 or A2.4 (see Table 1 ).
CTLs 1 : HLA-A2-restricted anti-H-YCTLs. These CTLs were prepared from the lymphocytes from a multitransfused woman suffering from aplastic anemia in partial remission (HLA-phenotypes: A2, Bw44, B40, Cw3, Cw5, DR4, DRw6). This patient received a bone marrow graft, which was subsequently rejected, from an HLA-identical male sibling donor. We have previously shown that her cells (after a 6-day in vitro sensitization period against irradiated peripheral blood lymphocytes from an HLA-A, B, C and -DR identical but mixed lymphocyte reaction positive unrelated male donor) were able to show preferential lysis of male target cells carrying the HLA-A2 antigen (Goulmy et al. 1977) . We refer to these CTLs as CTLs 1 or anti-H-Y CTLS.
C TLs 2: HLA-A2 and -BT-restricted anti-H-Y CTLs.
These CTLs were obtained from a multitransfused female aplastic anemia patient (HLA phenotype: A2, A28, B7, Bw62, Cw3, DR1, DR2). CTLs which specifically lysed HLA-A2 and HLA-B7 male target cells (Goulmy et al. 1979) were generated in vitro similarly to the method described and used for the generation of CTLs 1. We refer to these CTLs as CTLs 2 or anti-H-Y CTLs.
CTLs 3: HLA-A2, B27, Bw62-restricted antiminor HA-CTLs. Recently we demonstrated that posttransplant lymphocytes from a bone-marrow transplanted acute myeloid leukemia patient suffering from severe graft-versus-host disease, exhibited strong cytotoxicity in CML against his own pretransplant lymphocytes (Goulmy et al. 1982b.) . Additional studies showed that the patient's posttransplant cytotoxic effector cells recognize one (or more) minor transplantation antigen(s) in association with three self class I HLA molecules, namely, HLA-A2, -B27, and -Bw62 (Goulmy et al. 1983 a) . We refer to these CTLs as CTLs 3 or anti-minor "HA" CTLS.
Cell-mediated lympholysis assay (CML).
The CML assay has been described in detail previously (Goulmy 1982) . The HLA-restricted anti-H-Y and HLA-restricted antiminor HA CTLs as described above and designated as CTLs 1, 2 and 3 were mixed on the day of assay with 51Cr_labeled target cells in various CTL-to-target cell ratios in round-bottomed microtiter plates. Cytotoxicity (i. e., the amount of isotope released from 51Cr-labeled target cells) was determined and calculated according to the method described previously (Goulmy 1982) . All experiments were repeated at least twice at six effector-to-target ratios. Standard errors of the mean of triplicate determinations were less than 5%. When only one CTLto-target ratio was used, lysis levels equal to or less than 10% were considered negative, 11-15% weakly positive, 16-40% positive and greater than 40% strongly positive.
Results
Panel studies. Lymphocytes from 15 individuals, with the HLA-A2 subtypes A2.2, A2.3 and A2.4 and most of their relatives were tested with CTLs 1, 2 and 3 (see Materials and Methods). Table 1 shows the results of individuals 1-15 tested as target cells in CML against the three HLA-A2-restricted antiminor -H CTLs. The positive reactions that were observed were confined to the lymphocytes of individuals 10-15. The presence of the additional "normal" HLA-A2.1 major subtype (in individuals 11, 14 and 15) resulted in positive reactions with CTLs 1 and 2 against the lymphocytes of the male individuals 14 and 15, and a positive reaction with CTLs 3 against the lymphocytes of female individual 11. The presence of additional restricting elements, i.e., HLA-B27 and/or Bw62 (in individual 10 and 12), resulted in positive reactions with CTLs 3. The assumption that the positive reactions seen on target cells 10-15 are caused by the presence of either an additional normal HLA-A2.1 major subtype or other additional restricting elements (necessary for the associative recognition of the minor HA) is supported by segregation studies (see below). Anti-H-Y and antiminor HA CTLs showed no lysis against target cells carrying one of the HLA-A2 minor subtypes (except those from individual 13).
Family studies. Six families with different HLA-A2 subtypes were tested with CTLs 1, 2 and 3. Three informative families will be shown. We showed earlier that the HLA-A2 antigen subtypes are inherited codominantly (van der Poel et al. 1983a ). Investigation of the relatives of some individuals with the antiminor H-Y and antiminor HA CTLs revealed that those which carried haplotypes that included an HLA-A2 variant also lost their restricting epitopes for minor H-Y and minor HA. One such example is shown in Figure 1 . The father (01) of family I carries the HLA-A2 major subtype on the b haplotype; the mother (00) carries one HLA-A2.1 major subtype (haplotype c), and one HLA-A2 minor subtype on haplotype d. As is shown in Figure 1 , child 02 (male) with the maternal d haplotype (carrying the HLA-A2.2 subtype) is neither lysed by the two anti-H-Y CTLs nor by antiminor HA CTLs. However, child 03 (male) with the maternal c haplotype with the HLA-A2.1 (i. e., "normal") subtype was recognized normally by CTLs 1, 2, and 3.
The minor H antigen HA is recognized in association with the class I molecules A2, Bw62 and B27. Therefore we investigated the influence of HLA-A2 variant molecules on the recognition pattern of those antiminor HA CTLs. We chose family II in which the HLA-A2.2 subtype and one of the restricting elements (i. e., Bw62) were expressed. Figure 2 shows that the paternal lymphocytes carried the HLA-A2.1 major subtype; the maternal lymphocytes carried the Bw62 antigen in addition to the HLA-A2.2. subtype. As expected, the two types of antiminor H CTLs (H-Y and HA) lysed the lymphocytes of the father (01). Child 03 with the paternal b haplotype showed a similar pattern of lysis. When the mother's lymphocytes (00) were used as target cells, a positive reaction occurred only with the antiminor HA CTLs 3. The question of whether the positive reaction seen by CTLs 3 is due to associative recognition with the HLA-A2.2 antigenic determinant or with the HLABw62 antigen with the minor HA CTLs was investigated by analyzing the offspring. Child 02 inherited the maternal c haplotype. As shown in Figure 2 , no lysis was observed by the antiminor HA CTLs, indicating that the positive reaction on the maternal lymphocytes was not due to associative recognition with the HLA-A2.2 antigen but was caused by the recognition of the restricting molecule HLA-Bw62.
Next, the offspring of the "exception to the rule" (i. e., individual 13, whose lymphocytes were lysed by CTLs 1 and 2, see Table 1 ) was investigated with CTLs 1, 2 and 3. The results of the CTL analyses are shown in Figure 3 . Despite the fact that the father (individual 13 from the panel is No. 21 in the pedigree) carried an HLA- 
Discussion
Several subtypes of the serologically defined HLA-A and -B molecules have been determined by the use of cytotoxic T lymphocytes: HLA-A2 (Biddison et al. 1980 , Horai et al. 1982 , Spits et al. 1982 , van der Poel et al. 1983a ), HLA-A3 (Biddison et al. 1981) , B7 (Spits et al. 1982) , B27 , Bw35 (Goulmy et al. 1976 , Bradley et al. 1978 , B40 (Malissen et al. 1981) , and Bw44 (Kato et al. 1982) . The polymorphism of the serologically defined HLA-A2 antigen was first established by Biddison and co-workers (1980) by means of HLA-A2-restricted influenza virusspecific CTLs, later confirmed by HLA-A2-restricted anti-H-Y specific CTLs (Goulmy et al. 1982a ) and also by Epstein-Barr virus-specific CTLs (Gaston et al. 1983 ). HLA-A2 variants can also be detected easily by means of alloimmune HLA-A2-specific CTLs (Horai et al. 1982 , van der Poel et al. 1983a . The functional as well as biochemical analyses of the serological defined HLA-A2 molecules , van der Poel et al. 1983b ) have revealed considerable additional polymorphism in the determinants of the HLA-A2 serotype at the population level. This report presents the results of the analyses of HLA-A2 variants in 15 individuals using HLA-restricted antiminor H CTLs, i.e., minor H-Y CTLs and minor HA CTLs. They show that these antiminor H CTLs recognize, in general, the same epitope (or cluster of epitopes) as do the allo-CTLs to the HLA-A2.1 major subtype CTLs, the so-called "normal" HLA-A2 (Table 1 ). This conclusion is based on the identical reaction patterns obtained by "normal" alloimmune HLA-A2-specific CTLs and HLA-A2-restricted antiminor H CTLs against all (except one) variants classified as minor A2 subtypes, i. e., HLA-A2.2, A2.3 and A2.4. Consequently, our results suggest that associative recognition of minor H antigens requires an epitope (or epitopes) that is selectively present on the HLA-A2.1 molecule. Our conclusions may be homologous to the observations described by Weynand and co-workers (1981) , who reported a striking preference of alloreactive and H-2-restricted CTLs for the same domain of the H-2 molecule.
We reported earlier that HLA-A2 subtypes are inherited codominantly (van der Poel et al. 1983a) . Reaction patterns in six families with variant HLA-A2 determinants, obtained with our two types of HLA-restricted antiminor H CTLs, confirmed the latter observation. The three most informative families are described in this paper. The analysis of the lymphocytes of the family members of family I with the HLA-restricted antiminor H-Y and minor HA CTLs showed indeed that the HLA-A2 subtypes are inherited in a codominant way. Family 2 (Fig. 2) shows that the presence of the minor transplantation antigen HA can be demonstrated by MHC-restricted CTLs only through the presence of one of the structurally "correct" class I molecule. The lysis obtained against target cells of the mother of family II is derived through the presence of the Bw62 restricting element, as can be seen by the absence of lysis against target cells from child 02 who inherited the HLA-A2.2 subtype antigen and not Bw62. These results are concordant with the positive reactions in the panel study (Table 1) .
Finally, we discuss the exception to the rule which is demonstrated by individual 13. Target ceils of individual 13 carried the HLA-A2.4 subtype as demonstrated earlier by functional analysis (Horai et al. 1982 , van der Poel et al. 1983a ). Those Table 1 ). The analysis of the offspring of individual 13 (family III) revealed that the same reaction patterns were obtained with the antiminor H-Y CTLs on the lymphocytes of only those children which inherited the paternal HLA-A2.4 subtype. Thus, despite the presence of an HLA-A2 variant molecule, individual 13 and his offspring apparently retained the restricting epitope for recognition of the minor H-Y. Nevertheless, the lymphocytes of individual 13 and his children 01, 25 and 26 were not lysed by antiminor HA CTLs (Fig. 3) . Therefore, the latter target ceils lack the restricting epitope for the recognition of the minor HA, a situation which, in fact, is comparable with reaction patterns against all other HLA-A2 variants studied so far with the antiminor HA CTLs.
We cannot answer the question as to whether the lymphocytes of individual 13 carry the minor transplantation antigen HA. The possibility that all variants are negative for minor HA is very slight, since in a random population study only 5~o of the HLA-A2.1-positive individuals were found to be negative for minor HA (Goulmy et al. 1983 a, b) . Other HLA-A2 subtypes can only be typed for minor HA when they carry the restricting molecules Bw62 and/or B27 ( Fig. 2 and Table 1 ). Unfortunately, individual 13 does not carry one of those molecules and therefore cannot be typed for minor HA. Another explanation may be that the minor H-Y and minor HA antigen use two different epitopes for associative recognition. Both epitopes are present on HLA-A2.1 type molecules, but absent on A2.2 and A2.3 molecules. The A2.4 type molecules can be divided into two subtypes, one lacking both epitopes, as in individuals 1, 5 and 12, and one subtype containing the epitope for H-Y associative recognition, as in individual 13. Peptide mapping and amino acid sequencing of the HLA-A2 heavy chains of individual 1, 5, 12 and 13 may eventually resolve this issue. The results of analyses of some HLA-A2 variants by co-workers (1982, 1983) suggest that a tryptic peptide spanning residues 147 to 157 of the.HLA-A2 heavy chain may play an important role in the recognition of the HLA-A2 molecule by CTLs.
In conclusion, the'results of this study show that HLA-restricted antiminor H-Y and antiminor HA CTLs use, in general, the same epitope on the HLA-A2 molecule for associative cellular recognition.
